According to survival analysis, patients with high PHLDA1 expression had a worse prognosis than patients with low PHLDA1 expression, which suggested that PHLDA1 could be a possible prognostic marker for pancreatic cancer (Figures 9A, B). This evidence concerns the gene PHLDA1 and familial pancreatic carcinoma.